Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association · 2026
Cytokine markers in intracerebral hemorrhage are linked to ventricular imaging and outcomes.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Sorensen Gracey, Grychowski Lauren, Yan Jennifer, Remillard Will, Lidman Alice, Edwards Tori, Herman Alison L, Johnson Conor W, Sheth Kevin N, Matouk Charles, Falcone Guido J, Gilmore Emily J, Payabvash Seyedmehdi, Sansing Lauren H, Magid-Bernstein Jessica
Аннотация
OBJECTIVE: Central nervous system (CNS) inflammation after intracerebral hemorrhage (ICH) is substantial, but its relationship to radiographic severity and outcome remains unclear. Cerebrospinal fluid (CSF) obtained via external ventricular drains (EVDs) offers a direct window into CNS inflammation. We hypothesized that a stronger proinflammatory CSF cytokine response would be associated with ventricular enlargement and worse functional outcome.
METHODS: In this study, 56 ICH patients and 25 controls with normal pressure hydrocephalus were analyzed. CSF (days 0-16) and plasma (days 0-7) samples were. Concentrations of CC motif chemokine ligand 2 (CCL2), interleukin-6 (IL-6), interleukin-8 (IL-8), granulocyte colony-stimulating factor (G-CSF), and vascular endothelial growth factor A (VEGF-A) were measured. Ventricular volumes were derived from two computed tomography (CT) scans per patient (admission and EVD-clamp time point). Associations with ventricular volume change and 3-month modified Rankin Scale (mRS) were assessed using regression models.
RESULTS: Detectable CSF cytokines were elevated in ICH patients compared to control plasma (all p < 0.001), supporting compartmentalized CNS inflammation. Higher late CSF log[CCL2] was independently associated with greater ventricular enlargement (β = 33.41, 95% CI 7.22-59.60, p = 0.019; q = 0.034). Higher late CSF log[IL-6] (β=0.78, p = 0.011) and log[IL-8] (β=0.77, p = 0.009) remained independently associated with worse 3-month mRS.
CONCLUSIONS: CSF cytokines reflect the post-ICH central inflammatory response and are associated with ventricular enlargement and functional outcome, highlighting their potential as biomarkers of disease progression and therapeutic response post-ICH.
METHODS: In this study, 56 ICH patients and 25 controls with normal pressure hydrocephalus were analyzed. CSF (days 0-16) and plasma (days 0-7) samples were. Concentrations of CC motif chemokine ligand 2 (CCL2), interleukin-6 (IL-6), interleukin-8 (IL-8), granulocyte colony-stimulating factor (G-CSF), and vascular endothelial growth factor A (VEGF-A) were measured. Ventricular volumes were derived from two computed tomography (CT) scans per patient (admission and EVD-clamp time point). Associations with ventricular volume change and 3-month modified Rankin Scale (mRS) were assessed using regression models.
RESULTS: Detectable CSF cytokines were elevated in ICH patients compared to control plasma (all p < 0.001), supporting compartmentalized CNS inflammation. Higher late CSF log[CCL2] was independently associated with greater ventricular enlargement (β = 33.41, 95% CI 7.22-59.60, p = 0.019; q = 0.034). Higher late CSF log[IL-6] (β=0.78, p = 0.011) and log[IL-8] (β=0.77, p = 0.009) remained independently associated with worse 3-month mRS.
CONCLUSIONS: CSF cytokines reflect the post-ICH central inflammatory response and are associated with ventricular enlargement and functional outcome, highlighting their potential as biomarkers of disease progression and therapeutic response post-ICH.